作为真核生物对蛋白质聚合的保护机制的N-糖化
Ramon Duran-Romaña1,2, Bert Houben1,2, Matthias De Vleeschouwer1,2
1Switch Laboratory, VIB Center for Brain and Disease Research, 3000 Leuven, Belgium.
Science advances
|January 31, 2024
概括
作为一种蛋白质修饰的N-糖化,通过阻断聚合易发的区域,防止了更高的真核生物中有害的蛋白质聚合. 这一发现揭示了N-糖化在维持蛋白质稳定和预防疾病方面发挥的关键作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 蛋白质聚合是一种由聚合易发区域 (APR) 驱动的自然过程.
- 已知后翻译修饰 (PTMs) 影响蛋白质聚合,但它们在APR中的具体作用尚不清楚.
研究的目的:
- 调查PTMs在APRs调节蛋白质聚合中的参与.
- 确定N-糖化在防止蛋白质聚合中的特定作用.
主要方法:
- 整个蛋白质组的计算分析.
- 在体外生物物理技术.
- 分析现有的蛋白质组学数据和基于细胞的测试.
主要成果:
- 大多数PTM在APR附近处于不利地位,但N-糖化被丰富并在易于错误折叠的蛋白质中被进化选择.
- 在实验室中,N-糖基化通过硬质阻碍抑制了聚合.
- 在APR附近的N-甘氨酸的损失与Neuro2a细胞中的蛋白质聚合有关.
结论:
- N-糖化直接阻止了高层真核生物中的蛋白质聚合.
- 这种修饰在维持蛋白质静止和预防错误折叠相关疾病方面发挥着至关重要的作用.
相关概念视频
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Protein Glycosylation
6.9K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.9K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Protein Modifications in the RER
5.2K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.2K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


